Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.

Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects

Open access
Wu, Xiangyu, Li, Tianhang, Jiang, Rui, Yang, Xin, Guo, Hongqian, Yang, Rong · 2023 · Molecular Cancer

Abstract

The molecules of Major histocompatibility class I (MHC-I) load peptides and present them on the cell surface, which provided the immune system with the signal to detect and eliminate the infected or cancerous cells. In the context of cancer, owing to the crucial immune-regulatory roles played by MHC-I molecules, the abnormal modulation of MHC-I expression and function could be hijacked by tumor cells to escape the immune surveillance and attack, thereby promoting tumoral progression and impairing the efficacy of cancer immunotherapy. Here we reviewed and discussed the recent studies and discoveries related to the MHC-I molecules and their multidirectional functions in the development of cancer, mainly focusing on the interactions between MHC-I and the multiple participators in the tumor microenvironment and highlighting the significance of targeting MHC-I for optimizing the efficacy of cancer immunotherapy and a deeper understanding of the dynamic nature and functioning mechanism of MHC-I in cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12943-023-01899-4

Cites

163 of 163 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The modulation of MHC-I molecules-related antigenic processing and presentation mechanisms in cancer cell
Fig. 1 The modulation of MHC-I molecules-related antigenic processing and presentation mechanisms in cancer cellCC BY · PubMed Central
Fig. 2 The interaction between the cancer cell and immune cells in tumor microenvironment
Fig. 2 The interaction between the cancer cell and immune cells in tumor microenvironmentCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 163 references

Research works printed but not linked: 1

  1. van Montfoort N, Borst L, Korrer MJ, Sluijter M, Marijt KA, Santegoets SJ, van Ham VJ, Ehsan I, Charoentong P, Andre P, et al. NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer vaccines. Cell. 2018;175:1744. · DOI · Paper page

Cited by

See all 256

Metadata

Authors
Wu, X., Li, T., Jiang, R., Yang, X., Guo, H., & Yang, R.
Affiliations
  • Nanjing Drum Tower Hospital (CN)
  • Zhongda Hospital Southeast University (CN)
  • Fujian Medical University (CN)
Corresponding author
  • Guo, Hongqian
  • Yang, Rong
Venue
Molecular Cancer
Published
2023-12-02
Volume
22
Issue
1
Pages
194-194
ISSN
1476-4598 (ISSN-L)
OpenAlex
W4389266107
Cited by
223
References
163
Citations by year
2026: 78 · 2025: 109 · 2024: 34 · 2023: 2
FWCI
7.23
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81772710, 82172691)
  • Nanjing Science and Technology Development Key Project (YKK19011)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
MHC class I, cancer immunotherapy, tumor immune evasion, tumor microenvironment, peptide presentation, tumor progression, immune checkpoint blockade
MeSH terms
Cell Membrane, Humans, Immunotherapy, Neoplasms, Histocompatibility Antigens Class I, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects. https://app.cochat.ai/papers/10.1186/s12943-023-01899-4
The paper
Wu, X., Li, T., Jiang, R., Yang, X., Guo, H., & Yang, R. (2023). Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects. Molecular Cancer. https://doi.org/10.1186/s12943-023-01899-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.